Breast Cancer in Users of Levonorgestrel-Releasing Intrauterine Systems
This study uses data from nationwide Danish registries to assess breast cancer risk with continuous use of levonorgestrel-releasing intrauterine systems, accounting for other hormonal exposures.
Authors
- Lina Steinrud Mørch (ORCID: https://orcid.org/0000-0001-6506-2569)
- Amani Meaidi (ORCID: https://orcid.org/0000-0003-4549-8271)
- Marie Hargreave (ORCID: https://orcid.org/0000-0001-6821-9242)
- Charlotte Wessel Skovlund (ORCID: https://orcid.org/0000-0002-6234-359X)
- Giulia Corn (ORCID: https://orcid.org/0000-0002-2858-1746)
Institutions
- Danish Cancer Society (DK)
Publication Details
- Journal
- JAMA
- Published
- 2024-10-16
- DOI
- https://doi.org/10.1001/jama.2024.18575
- Citations
- 27
- Primary Topic
- Cancer Risks and Factors
- Type
- article
- Field-Weighted Citation Impact
- 7.63